The MaxCyte® STX™ Scalable Transfection System enables rapid development and consistent production of transfected cells for use in High Throughput Screening (HTS), High Content Screening (HCS), and other cell-based assays for ion channels, GPCRs, and other targets. The MaxCyte STX transfects primary cells, cell lines, and stem cells with multiple agents simultaneously, with high loading efficiency, cell viability, reproducibility, and consistency with Seamlessly ScalableTM results from small (5E5 cells in seconds) to large scale (1E10 cells in 20-30 minutes).

The MaxCyte STX can help you develop assays faster, and in more biologically relevant cell types, increasing the productivity of your laboratory and improving the quantity and quality of your drug candidates.

How the MaxCyte STX Works

STX Video

Click on the image above to see a video on the operation of the MaxCyte STX Scalable Transfection System.
Watch the video in Japanese (.wmv)

MaxCyte STX Features

Simple:       Ease and flexibility of use.
Broad Range: Cell lines, primary cells, stem cells.
Loading Agents: DNA, RNA, proteins, small molecules.
High Yield: >90% viability for many cell types.
High Efficiency: >90% loading & transfection efficiency for many cell types.
Safe: Chemically defined media.
Rugged: Reproducible & consistent processing.
Scalable: ~5E5 cells in <1minute to 1E10 cells in <30 minutes.
Quality: cGMP compliant, ISO-certified, CE marked.
Regulatory: Master File on record with USFDA.
          















Applications

  Primary Cells: Table
 Cell Lines: Table
 Application Notes


HEK 293 cells after transfection with the MaxCyte STX Scalable Transfection System.
 
Vero cells after transfection with the MaxCyte STX Scalable Transfection System.

Resources

  MaxCyte STX Brochure (PDF, 500kb)
 Posters, Abstracts, Press Releases, and Publications
 The MaxCyte© Minute Newsletter
 Webinar Archives



Contact
For more information, please click here.

Orders
Orders can be placed via fax to 301-944-1703 or email to orders@maxcyte.com.

MaxCyte's technology is protected by U.S. and international patents. The MaxCyte STX Scalable Transfection System is available for royalty free non-clinical research and screening applications under a limited label license. Clinical applications require a special license and agreement with MaxCyte. Please contact us for details.